Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year

Documenti analoghi

• Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
  di: Abraham Zlotogorski, et al.
  Pubblicazione: (2024)
• Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
  di: M. Senna, et al.
  Pubblicazione: (2024)
• Giant Merkel cell carcinoma of the scalp
  di: Junyou Zheng, et al.
  Pubblicazione: (2026)
• Psychodermatological scalp syndromes: Splitting the hair for diagnostic precision
  di: Hitaishi Mehta, et al.
  Pubblicazione: (2025)
• Trichoscopy as a monitoring tool in assessing treatment response in scalp pemphigus
  di: M. Starace, et al.
  Pubblicazione: (2024)